Skip to Content

Search

“The needs of our olympic athletes and grandparents differ by degree, not kind.” That is to say, everyone needs to perform an intelligently selected variety of functional movements at a level of intensity appropriate for that individual. Everyone needs to eat food that sustains, rather than harms, the body. This is the pursuit of fitness, and the ability to maintain that fitness throughout your life is a defining measure of health. CrossFit At Home is a place to access the necessary tools—functional movement, simple nourishment—to sustain and preserve your health at home.

NY Times

"A popular diabetes drug sometimes taken to slow aging may diminish some of the expected health benefits of aerobic exercise in healthy older adults, according to a new report. The drug, metformin, can blunt certain physical changes from exercise that normally help people to age well. The results raise questions about the relationship of pills and physical activity in healthy aging and also whether we know enough about how drugs and exercise interact. The results are particularly disconcerting given that healthy, active people may be considering taking the drug to slow aging. Metformin currently is the most-prescribed medication globally for people with Type 2 diabetes."

Read the article An Anti-Aging Pill? Think Twice
the daily beast logo

"In March, the Food and Drug Administration approved a ketamine cousin called esketamine, taken as a nasal spray, for patients with intractable depression. With that, the esketamine nasal spray, under the brand name Spravato, was introduced as a miracle drug—announced in press releases, celebrated on the evening news and embraced by major health care providers like the Department of Veterans Affairs. The problem, critics say, is that the drug’s manufacturer, Janssen, provided the FDA at best modest evidence it worked and then only in limited trials. It presented no information about the safety of Spravato for long-term use beyond 60 weeks. And three patients who received the drug died by suicide during clinical trials, compared with none in the control group, raising red flags Janssen and the FDA dismissed."

Read the article FDA Overlooked Red Flags In Testing of New Depression Drug

Comments on undefined